Discover how Secondary Intelligence™ can support your compound assessments by predicting off-target activities and potential adverse events. Join Claire Clare Gilmer PhD as she introduces the latest ToxStudio® software features:
1. Visualize secondary pharmacology data
2. Compare test compound coverage with drugs targeting specific receptors
3. Predict safety outcomes in both in vivo and clinical settings
Enhance decision-making while optimizing drug safety and efficacy with Secondary Intelligence™. Watch now.
